Multiple Sclerosis eEDSS – Data Science Point of View
Costas Boussios, Chief Data Scientist, OM1 details estimated EDSS score for Multiple Sclerosis were developed.
Showing 21-25 of 84 clinical outcomes & condition measurement and management:
Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study
Taylor & Francis Online April 6, 2023 Read the full manuscript >> Objective: To investigate the impact of steroid-eluting implants after endoscopic sinus surgery (ESS) on health care resource use (HCRU) in chronic rhinosinusitis patients with (CRSwNP) and without (CRSsNP) nasal polyps. Methods: This retrospective, observational cohort study using real-world evidence data included adult patients[…]
RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity
Dermatology Times Mar 19, 2023 Kaitlyn Bader Read the Full Article >> A poster presentation from AAD 2023 explored RAPID3 scores to evaluate patient-reported outcomes in routine clinical practice therapy decisions regarding PsA. There is a lack of evidence investigating the impact of patient-reported outcomes (PROs) monitoring in routine clinical practice, according to a[…]
Interview with OM1’s Jessica Paulus at SCOPE
Published on: March 9, 2023 Applied Clinical Trials Watch the Full Interview >> Key Learning Objectives: Challenges people encounter when working with RWD How can RWD help address gaps in care? How OM1 engages or supports health equity research using RWD
2022 Year in Review: Real-World Data & AI
2022 has been a busy and productive year for OM1 in Real-World Data (RWD), Real-World Evidence (RWE), and Artificial Intelligence (AI). In this debut newsletter, we highlight industry trends and how OM1 is rising to meet those challenges and innovating to develop new opportunities. Please complete the form to download the newsletter. Download >> *Due[…]